Skip to main content

Table 1 Reported adverse outcomes

From: Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: a systematic review and meta-analysis of published randomized controlled trials

Trials

Adverse events reported

Follow up (weeks)

Blonde 2016 [9]

Any AEs, AEs leading to drug discontinuation, hypoglycemia episodes

104

Forst 2014 [10]

Any AEs, AEs leading to discontinuation, serious AEs, deaths, UTI

52

Neal 2015 [11]

Any AEs, AEs causing discontinuation, serious AEs, deaths, UTI, documented and severe hypoglycemia

18

Gonzalez 2013 [12]

Any AEs, AEs leading to discontinuation, serious AEs, UTI, postural dizziness

52

Inagaki 2013 [13]

Hypoglycemia

12

Inagaki 2014

Discontinuation due to AEs

52

Stenlof 2013 [15]

Any AEs, AEs leading to discontinuation, serious AEs, death, UTI, postural dizziness

26

Wilding 2013 [16]

Any AEs, AEs leading to discontinuation, serious AEs, deaths, UTI, hypoglycemia

52

Yale 2013 [17]

Any AEs, AEs leading to discontinuation, serious AEs, deaths, UTI, postural dizziness

26

Rosenstock 2012 [18]

Any AEs, serious AEs, discontinuation due to AEs, UTI, hypoglycemia

12

  1. Abbreviations: AEs adverse events, UTI urinary tract infections